Ultime notizie per Exicure (NASDAQ:XCUR) Azioni

Exicure

Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.

XCUR

Cinque azioni da tenere d&#39;occhio oggi, inclusi Darden Restaurants e FedEx, con risultati trimestrali pronti a sorprendere.

Pre-market: 5 titoli da monitorare oggi C

Earnings

News

Pre-Market Outlook

Markets

Trading Ideas

CODA

RFIL

VNCE

Coda Octopus, Exicure e altri titoli in movimento nel pre-market: ecco cosa aspettarsi oggi 16 settembre 2024.

Pre-market: 5 titoli da monitorare oggi, 16 settembre 2024

Exicure Inc

Curate

On Sunday, University of Michigan economist Justin Wolfers highlighted the unusual carveouts in the new U.S.-U.K. trade framework, with leading British brands such as Rolls-Royce Plc, Aston Martin, Bentley, and several other high-end automakers effectively dodging the tariffs.
What Happened: During his appearance on Times Radio, Wolfers called the decision &#8220;politically insane,&#8221; arguing that it undermines the administration's stated goal of protecting American workers and reshoring production.
Wolfers finds it amazing that President Donald Trump said &#8220;we've got to give them a break on the Rolls-Royces because they're beautifully made, handcrafted cars,&#8221; since the &#8220;whole point of the tariffs is to bring production to America,&#8221; he says.
See Also: <a href="https://www.benzinga.com/25/05/45341851/ross-gerber-calls-waymos-self-driving-taxis-better-than-human-says-theyre-tough-competition-for-uber-and-tesla">Ross Gerber Calls Google-Backed Waymo&#8217;s Self-Driving Taxis &#8216;Better Than A Human,&#8217; Says They&#8217;re &#8216;Tough Competition&#8217; For Uber And Tesla</a>
&#8220;We have tariffs on bananas, something no American worker is ever going to learn to grow,&#8221; Wolfers said, pointing to similarly inexplicable duties on vanilla and diamonds, which the U.S. can't produce or mine. And yet, &#8220;the one thing we definitely can't do [without] is Rolls-Royces, so that gets a special carveout.&#8221;
Wolfers wonders if &#8220;these people&#8221; just see the parking lot at Mar-a-Lago and think &#8220;well that's what people drive, that will help working and middle class Americans,&#8221; highlighting the absurdity of this move.
Why It Matters: Wolfers has repeatedly criticized the aimless, shifting goalposts and <a href="https://benzinga.com/markets/25/04/45091467/trump-can-either-have-his-cake-or-eat-it-economist-justin-wolfers-calls-out-presidents-fundamental-incoherence-on-trade-deals-and-tariffs">&#8220;fundamentally incoherent&#8221; nature</a> of Trump&#8217;s tariffs. Just a week ago, he stated that Trump can either have a deal or tariff revenue, no both.
Just a day after the &#8220;Liberation Day&#8221; tariffs were unveiled, Wolfers called it &#8220;monstrously destructive,&#8221; and something <a href="https://benzinga.com/markets/equities/25/04/44620423/trumps-sweeping-tariffs-could-cost-us-20-trillion-crash-markets-warn-economists-monstrously-destructive">that would hurt</a> &#8220;working Americans more than anyone else.&#8221;
Automakers General Motors Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GM#NYSE">GM</a>), Ford Motor Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/F#NYSE">F</a>) and Stellantis NV (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STLA#NYSE">STLA</a>) have joined in on the criticism of <a href="https://benzinga.com/25/05/45314561/trumps-uk-trade-deal-draws-criticism-from-ford-gm-stellantis-this-hurts-american-automakers-suppliers-and-auto-workers">Trump&#8217;s trade deal</a> with U.K., saying that &#8220;it will now&nbsp;be cheaper to import a&nbsp;U.K. vehicle with very little&nbsp;U.S. content than a USMCA&nbsp;compliant vehicle from Mexico or&nbsp;Canada that is half American&nbsp;parts.&#8221; 
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="‘If I was British I'd be p&#x2A;&#x2A;sed' Trump's UK deal is not the end of the trade war &#x7C; Justin Wolfers" width="500" height="281" src="https://www.youtube.com/embed/171Q2oZBJL4?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45341262/trumps-millionaire-tax-more-of-a-symbolic-gesture-than-step-towards-reducing-inequality-warn-experts-its-going-to-give-a-lot-of-republicans-heartburn">Trump&#8217;s Millionaire Tax More Of A Symbolic Gesture Than Step Towards Reducing Inequality, Warn Experts: &#8216;It&#8217;s Going To Give A Lot Of Republicans Heartburn&#8217;</a></li>
</ul>
Image Via Shutterstock

Government

Economics

STLA

Trump's UK Trade Carveouts Baffles Economist Justin Wolfers: Bentley, Rolls-Royce Exemption Is 'Politically Insane'

<ul>
<li>The REAL8 trial showed that after 52 weeks, once-weekly Sogroya (somapacitan) had similar clinical outcomes and safety profile to once-daily Norditropin (somatropin) in children born small for gestational age (SGA)1, or with Noonan syndrome (NS)2, or with idiopathic short stature.</li>
<li>Superiority was achieved for once-weekly somapacitan versus daily growth hormone in children with NS2, as well as compared to lower doses of daily growth hormone in children born SGA1.</li>
<li>These conditions are often associated with significant health challenges and a high treatment burden from daily injections, which can lead to a lack of adherence and put successful treatment outcomes at risk. Novo Nordisk is committed to bringing our expertise and scientific innovation to help improve the lives of children with conditions that impact their growth.</li>
</ul>

Biotech

Large Cap

Health Care

General

Novo Nordisk Presented Data From Phase 3 REAL8 Basket Study, Which Showed That Once-weekly Sogroya (Somapacitan) Was Non-inferior To The Once-daily Growth Hormone Norditropin (Somatropin) In Improving Yearly Growth Rate In Children With Growth Disorders

Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) has touted the company's FSD (Full Self-Driving) technology ahead of next month's Robotaxi launch in Austin, Texas.
What Happened: A video posted by a handle on X called Whole Mars Catalog showcased a Tesla vehicle navigating its way through traffic using Supervised FSD near Los Angeles's LAX airport on Saturday.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Tesla FSD drops off a passenger at Los Angeles International Airport <a href="https://t.co/gnLTTExAdr">pic.twitter.com/gnLTTExAdr</a>
&mdash; Whole Mars Catalog (@WholeMarsBlog) <a href="https://twitter.com/WholeMarsBlog/status/1921159647530012722?ref_src=twsrc%5Etfw">May 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Tesla's official handle on X then quoted the video on Sunday. "LAX is no problem for FSD Supervised," the EV giant said in the post. The post was also reposted by Tesla CEO Elon Musk.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">LAX is no problem for FSD Supervised <a href="https://t.co/IXWJbUUjhx">https://t.co/IXWJbUUjhx</a>
&mdash; Tesla (@Tesla) <a href="https://twitter.com/Tesla/status/1921525298702561392?ref_src=twsrc%5Etfw">May 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Why It Matters: As Musk's EV giant is gearing itself up for the launch of its robotaxi in Austin, the company has hit a snag as the U.S. Patent and Trademark Office <a href="https://www.benzinga.com/25/05/45278182/elon-musks-cybercab-ambitions-face-latest-snag-teslas-robotaxi-trademark-filing-refused-by-authorities">refused to grant </a>the company trademarks on "Robotaxi" as well as "Cybercab."
Elsewhere, Tesla asked its workers to stay at home as the company extended the <a href="https://www.benzinga.com/25/05/45334371/tesla-workers-told-to-stay-home-as-elon-musks-ev-giant-extends-memorial-day-break-following-13-delivery-drop-and-surging-inventory-report">Memorial Day break </a>amid a 13% drop in deliveries and <a href="https://www.benzinga.com/markets/25/05/45216453/tesla-has-over-10000-units-of-unsold-cybertrucks-in-its-us-inventory-amid-poor-sales-report">inventory piling up</a> at Tesla dealerships.
On the other hand, the EV manufacturer continues to wrestle with poor sales figures both within the U.S. as well as in regions like Europe. Recently, the company also <a href="https://www.benzinga.com/tech/25/04/45004433/tesla-rolls-out-free-fsd-transfers-on-all-us-models-including-cybertruck-amid-poor-sales">offered free FSD transfers</a> for its customers on all of its models in a bid to boost sales.
However, analysts are still optimistic about Musk's company's future as analyst Gary Black believes that Tesla will <a href="https://www.benzinga.com/markets/equities/25/05/45341220/top-bull-gary-black-shares-why-he-is-holding-on-to-uber-and-tsla-our-investment-thesis-on">reap the benefits</a> of increased EV adoption as well as autonomous driving.
Price Action: TSLA gained 7.41% in Pre-Market trading and is currently valued at $320.35, according to<a href="https://pro.benzinga.com/dashboard"> Benzinga Pro data</a>.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/05/45336365/tesla-fired-employee-who-created-website-criticizing-billionaire-elon-musk-report">Tesla Fired Employee Who Created Website Criticizing Billionaire Elon Musk: Report</a></li>
</ul>
Image Via Shutterstock

Tech

TSLA

Elon Musk's Tesla Teases FSD Capabilities Ahead Of June Robotaxi Event

Dogwifhat (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">WIF</a>) spearheaded the broader cryptocurrency rally early Monday morning, fueled by optimism about the U.S.-China trade deal.
What happened: The Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>)-based meme coin soared 46% to become the second-most successful cryptocurrency in the last 24 hours. The coin's trading volume surged nearly 50% to $1.14 billion.
The rally pushed WIF's weekly gains to 124% and monthly gains past 192%.
The upsurge dwarfed the gains made by top meme coins like Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) and Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>), which rose 4.20 and 4.67%, respectively.
See Also:<a href="https://www.benzinga.com/25/04/44621245/gold-backed-cryptos-match-yellow-metals-highs-following-trumps-liberation-day-shock"> </a><a href="https://www.benzinga.com/25/05/45339966/bitcoin-creator-satoshi-nakamotos-estimated-wealth-crosses-bill-gates-amid-apex-cryptos-sharp-rebound">Bill Gates Left Behind By Satoshi Nakamoto: Bitcoin Creator&#8217;s Wealth Now Eclipses That Of Microsoft Co-Founder Amid Crypto&#8217;s Sharp Rebound</a>
Ansem, a veteran cryptocurrency trader and early investor in WIF, described the memecoin's chart as &#8220;very clean.&#8221; He also reshared Dogwifhat's slogan &#8220;Hat stays on," indicating his bullish outlook.&nbsp;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">in all honesty <a href="https://twitter.com/search?q=%24WIF&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$WIF</a> looks very clean, think invalidation is around ~$0.75-$0.80 high timeframe but a lot of alts look similar to this, hype &amp; fartcoin were just first to move but didn&#39;t believe at all that alts would follow on these breakouts <a href="https://t.co/Vl33yXXYEN">pic.twitter.com/Vl33yXXYEN</a>
&mdash; Ansem &#x1f402;&#x1f004;&#xFE0F; (@blknoiz06) <a href="https://twitter.com/blknoiz06/status/1921766224079335531?ref_src=twsrc%5Etfw">May 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Another cryptocurrency trader, going by the pseudonym Crypto Mechanic, acknowledged that the coin made a "great" move, but now may not be the best time to buy.
"Let the price go into consolidation or give you some LTF pullbacks that would be a less risky setup imo," the trader said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Meme coins attract the most volume when the market shows some strength.<a href="https://twitter.com/search?q=%24WIF&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$WIF</a> did a great move but if you are thinking to buy now i think you are late to the party. Let the price go into consolidation or give you some LTF pullbacks that would be a less risky setup imo. <a href="https://t.co/D6aXOq5KTz">pic.twitter.com/D6aXOq5KTz</a>
&mdash; Crypto Mechanic (@CryptomechanicX) <a href="https://twitter.com/CryptomechanicX/status/1921824844523405631?ref_src=twsrc%5Etfw">May 12, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Launched in November 2023, dogwifhat is characterized by a Shiba Inu dog wearing a pink knitted hat. The Shiba Inu theme has been deeply rooted in the meme coin space since Dogecoin's launch.
The spike followed a broader cryptocurrency rally spurred by the <a href="https://www.benzinga.com/trading-ideas/movers/25/05/45339289/bitcoin-taps-105000-ethereum-steady-dogecoin-falls-as-us-announces-china-trade-deal-analyst-says-btc-in-for-a-price-discovery-uptrend-if-it-secures-a-weekly-close-above-this-lev">announcement of a trade deal</a> between the U.S. and China.
Price Action:&nbsp; At the time of writing, WIF was exchanging hands at $1.26, up 46.74% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45339772/michael-saylor-harnesses-ai-to-drive-home-an-important-message-on-bitcoin-its-going-up-forever">Michael Saylor Harnesses AI To Drive Home An Important Message On Bitcoin: &#8216;It&#8217;s Going Up Forever&#8217;</a></li>
</ul>
Image Via Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Movers

$DOGE

$SHIB

$SOL

$WIF

Why Is This Dogecoin Clone Surging On Monday Morning?

Ensign Energy Services (TSX:<a class="ticker" href="https://www.benzinga.com/stock/ESI#TSX">ESI</a>) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $(0.04) by 150 percent. This is a 300 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $436.51 million which beat the analyst consensus estimate of $421.22 million by 3.63 percent. This is a 1.21 percent increase over sales of $431.31 million the same period last year.

Earnings Beats

TSX:ESI

Ensign Energy Services Q1 EPS $0.02 Beats $(0.04) Estimate, Sales $436.51M Beat $421.22M Estimate

On Sunday, India issued its first official response after reports emerged that a Rafale fighter jet, part of the country's prized air fleet, was allegedly shot down by a Chinese-made Pakistani aircraft.
What Happened: The unverified incident, which sent shockwaves across defense circles, rattled the investors, with shares of French manufacturer Dassault Aviation plunging amid growing scrutiny over the jet&#8217;s battlefield performance
On Friday, U.S. officials confirmed that a Chinese-made J-10 aircraft fired air-to-air missiles at Indian fighter jets. One of the Indian jets shot down was a French-built Rafale fighter, while Pakistan&#8217;s U.S.-made F-16s, produced by Lockheed Martin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LMT#NYSE">LMT</a>), were not involved in the incident, reported Reuters.
Pakistan&#8217;s Defense Minister, Khawaja Muhammad Asif, claimed that the J-10 was used to shoot down three Rafale planes, newly acquired by India. Pakistan asserts to have downed five Indian planes in total.
On Sunday, Air Marshal A.K. Bharti responded in a press conference regarding the same. &#8220;We are in a combat scenario and losses are a part of it. All our pilots are back home,&#8221; stated Bharti. 
Notably, the Indian military gave no clear answer on this.
The incident led to a decline in shares for Rafale manufacturer Dassault Aviation (OTC:<a class="ticker" href="https://www.benzinga.com/stock/DUAVF#OTC">DUAVF</a>). The European listed stock has fallen nearly 10% in the last 5 days. On Friday, the U.S.-listed ADRs closed lower by more than 3.6%. Over the past five days, the ADR lost 4.42% of its value.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/05/45338281/trump-has-a-proven-track-record-of-being-an-absolute-failure-says-gov-tim-walz-we-dont-need-to-run-governmen" target="_blank" rel="noreferrer noopener">Trump Has A &#8216;Proven Track Record Of Being An Absolute Failure,&#8217; Says Gov. Tim Walz—&#8217;We Don&#8217;t Need To Run Government Like A Business&#8217;</a>
Why It Matters: The incident has piqued the interest of air warfare communities worldwide, eager to understand the tactics, techniques, and procedures used in the confrontation. Washington is closely analyzing the jet's performance against a Western adversary, seeing it as a potential indicator of how Beijing might fare in a conflict over Taiwan or across the broader Indo-Pacific.
The incident comes amid <a href="https://www.benzinga.com/25/05/45241770/india-fires-missiles-into-pakistani-territory-trump-hopes-fighting-between-nuclear-rivals-ends-very-quickly">escalating tensions </a>between India and Pakistan. On May 7, India launched missile strikes into Pakistani-controlled territory <a href="https://www.benzinga.com/25/05/45241770/india-fires-missiles-into-pakistani-territory-trump-hopes-fighting-between-nuclear-rivals-ends-very-quickly">as part of </a>Operation Sindoor to avenge the alleged killings of tourists reportedly by a Pakistani terror group in Pahalgam, Kashmir.
Following this, a <a href="https://www.benzinga.com/news/global/25/05/45335338/trump-makes-india-pakistan-ceasefire-declaration-in-casual-manner-thank-you-for-your-attention-to-this-matter">U.S.-brokered ceasefire </a>was announced by President Donald Trump. However, the ceasefire was short-lived as explosions in Srinagar and Jammu <a href="https://www.benzinga.com/markets/equities/25/05/45336288/india-pakistan-ceasefire-teeters-as-blasts-shatter-calm-in-kashmir">raised doubts </a>about the truce&#8217;s longevity.
The two nations are set to hold talks on Monday. 
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/25/05/45339966/bitcoin-creator-satoshi-nakamotos-estimated-wealth-crosses-bill-gates-amid-apex-cryptos-sharp-rebound" target="_blank" rel="noreferrer noopener">Bill Gates Left Behind By Satoshi Nakamoto: Bitcoin Creator&#8217;s Wealth Now Eclipses That Of Microsoft Co-Founder Amid Crypto&#8217;s Sharp Rebound &#8211; Benzinga</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Equities

DUAVF

India Breaks Silence After Rafale Jet Reportedly Downed By Pakistan's Chinese-Made Fighter — Triggering Sell-Off In Dassault Aviation Stock: 'Losses Are A Part Of...'

Berkshire Hathaway Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) has silently emerged as one of the biggest players in the U.S. Treasury-bill market. In JPMorgan's estimation, Warren Buffett's conglomerate currently holds around 5% of all outstanding short-term government bills. This makes it the fourth-largest holder in the world.
What Happened: Berkshire's T-bill holdings have increased to $314 billion as of the end of March, multiplying twofold in the past year, outpacing even the holdings of foreign banks, the Federal Reserve, Local Government Investment Pools, offshore money market funds, and stablecoin-backed reserves, according to JPMorgan, <a href="https://www.cnbc.com/2025/05/11/berkshire-now-owns-5percent-of-treasury-bill-market-as-buffett-waits-for-prey.html">reported</a> CNBC.
Buffett regularly buys T-bills at weekly auctions, at times in $10 billion chunks. With short-term yields still more than 4%, the portfolio earns billions in interest income every year.
See Also: <a href="https://www.benzinga.com/markets/cryptocurrency/25/05/45280752/warren-buffetts-berkshire-delivered-a-16000-gain-since-listing-but-bitcoin-the-asset-he-called-rat-poison-turned-pennies-into-fortunes-faster">Warren Buffett&#8217;s Berkshire Delivered A 16,000% Gain Since Listing— But Bitcoin, The Asset He Called &#8216;Rat Poison,&#8217; Turned Pennies Into Fortunes Faster</a>
Why It Matters: During Berkshire's recent annual meeting, 94-year-old Buffett reminded shareholders that cash has intrinsic strategic value: "Every now and then you find something and occasionally, very occasionally, but it'll happen again… we will be bombarded with offerings that we'll be glad we have the cash for." He also shared that the company had almost spent $10 billion in the recent past but decided to hold back. "We came pretty close to spending $10 billion, not that long ago, for example, but we'd spend $100 billion" if the right deal came along, Buffett said.
At the same meeting, he also <a href="https://www.benzinga.com/general/market-summary/25/05/45218040/warren-buffett-expresses-disappointment-over-dollar-depreciation-dont-want-to-own-assets-in-a-currency-that-is-really-going-to-hell">expressed concerns</a> about the falling value of the United States currency. Earlier this month, Berkshire Hathaway reported a <a href="https://www.benzinga.com/news/earnings/25/05/45183890/berkshire-hathaways-q1-2025-earnings-plunge-amid-tariff-concerns-operating-profit-fell-14-cash-hit-a-record">major drop</a> in its operating earnings in the first quarter.
As he prepares to <a href="https://www.benzinga.com/25/05/45187070/warren-buffett-retires-after-decades-of-dominancefrom-tim-cook-to-mark-cuban-worlds-top-business-leaders-react-to-the-investment-icons-exit">step down as CEO</a> at the end of the year year &#8212; which led to <a href="https://www.benzinga.com/news/management/25/05/45199066/berkshire-hathaway-stock-falls-following-buffetts-retirement-as-ceo">Berkshire Hathaway stocks falling</a> &#8212; the Oracle of Omaha leaves behind a company equipped with cash and patience, waiting for the next big elephant.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/25/05/45314762/charlie-munger-was-once-asked-why-warren-buffett-was-so-much-richer-and-replied-he-got-an-earlier-start-before-adding-why-was-albert-einstein-poorer-than-i-was">Charlie Munger Was Once Asked Why Warren Buffett Was So Much Richer — He Replied, &#8216;He Got An Earlier Start,&#8217; Then Added, &#8216;Why Was Albert Einstein Poorer Than I Was?&#8217;</a></li>
</ul>
Image Via Shutterstock

Warren Buffett's Cash Mountain Grows To $314 Billion As Berkshire Hathaway Emerges As Top Treasury-Bill Holder: 'We'd Spend $100 Billion' If the Right Deal Came Along, Says Oracle Of Omaha

Shares of Sable Offshore Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOC#NYSE">SOC</a>) rose sharply in today's pre-market trading after the company reported <a href="https://www.benzinga.com/quote/SOC">results for the first quarter.</a>
The company reported a net loss of $109.5 million for the quarter.
Sable Offshore shares jumped 12.6% to $25.90 in the pre-market trading session.
Here are some other stocks moving in pre-market trading.
<h3 class="wp-block-heading">Gainers</h3>
<ul class="wp-block-list">
<li>Jayud Global Logistics Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JYD#NASDAQ">JYD</a>) rose 171.2% to $0.5896 in pre-market trading.</li>
<li>Next Technology Holding Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTT#NASDAQ">NXTT</a>) surged 161.8% to $6.18 in pre-market trading after jumping 661% on Friday. The company said as of March 31, it held ~5,833 Bitcoins with a carrying value of $481.7 million.</li>
<li>Metallus Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MTUS#NYSE">MTUS</a>) gained 45.5% to $16.90 in pre-market trading. Metallus shares dipped 11% on Friday after the company reported mixed first-quarter financial results.</li>
<li>Taoping Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TAOP#NASDAQ">TAOP</a>) jumped 30.1% to $0.2129 in pre-market trading after dipping 19% on Friday.</li>
<li>DDC Enterprise Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDC#NYSE">DDC</a>) gained 28.8% to $3.16 in pre-market trading after gaining 12% on Friday.</li>
<li>LQR House Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YHC#NASDAQ">YHC</a>) surged 22.5% to $2.44 in pre-market trading after gaining more than 5% on Friday.</li>
<li>Ryde Group Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RYDE#NYSE">RYDE</a>) climbed 18.8% to $0.2674 in pre-market trading.</li>
<li>Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SHPH#NASDAQ">SHPH</a>) gained 16.2% to $0.27 in pre-market. Shuttle Pharmaceuticals recently announced FDA orphan-drug nears patient enrollment milestone for phase 2 clinical trial.</li>
<li>Olema Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>) gained 15.2% to $5.30 in pre-market trading.</li>
</ul>
<h3 class="wp-block-heading">Losers</h3>
<ul class="wp-block-list">
<li>Abits Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ABTS#NASDAQ">ABTS</a>) shares dipped 48.2% to $4.35 in pre-market trading after jumping 262% on Friday.</li>
<li>Nuvve Holding Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVVE#NASDAQ">NVVE</a>) shares fell 37.7% to $1.73 in pre-market trading after surging 144% on Friday. Nuvve engaged Crypto Venture Group to accelerate digital asset strategy.</li>
<li>Incannex Healthcare Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IXHL#NASDAQ">IXHL</a>) shares fell 29.3% to $0.0801 in pre-market trading.</li>
<li>Siyata Mobile Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SYTA#NASDAQ">SYTA</a>) fell 28.1% to $1.20 in pre-market trading after jumping 70% on Friday.</li>
<li>Global IBO Group Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GIBO#NASDAQ">GIBO</a>) fell 24.1% to $5.30 in today's pre-market trading after jumping 102% on Friday.</li>
<li>ReShape Lifesciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) shares tumbled 22.7% to $5.15 in pre-market trading. ReShape Lifesciences filed for mixed shelf offering of up to $50 million.</li>
<li>DevvStream Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DEVS#NASDAQ">DEVS</a>) fell 21.2% to $0.2634 in pre-market trading.</li>
<li>Shineco, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SISI#NASDAQ">SISI</a>) dipped 20.2% to $0.67 in pre-market trading after gaining more than 5% on Friday.</li>
<li>Seabridge Gold Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SA#NYSE">SA</a>) declined 9.4% to $11.38 in pre-market trading.</li>
<li>Gold Fields Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GFI#NYSE">GFI</a>) fell 9.2% to $20.45 in pre-market trading.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45315727/top-3-industrials-stocks-that-may-collapse-in-may">Top 3 Industrials Stocks That May Collapse In May</a> </li>
</ul>
Photo via Shutterstock

ABTS

DEVS

GIBO

IXHL

MTUS

NVVE

Next Technology Holding Inc. - Ordinary Shares

NXTT

OLMA

RSLS

RYDE

SHPH

SISI

SYTA

TAOP

Why Sable Offshore Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket

<a href="https://www.cnbc.com/2025/05/12/us-and-china-agree-to-slash-tariffs-for-90-days.html" title="https://www.cnbc.com/2025/05/12/us-and-china-agree-to-slash-tariffs-for-90-days.html">https://www.cnbc.com/2025/05/12/us-and-china-agree-to-slash-tariffs-for-90-days.html</a>

Macro Economic Events

Earlier: U.S., China Agree To  Slash Tariffs For 90-Days, Cutting Reciprocal Tariffs From 125% To 10% While U.S. Keeps 20% Duties On China's Fentanyl-Linked Imports, Leaving Total Tariffs On China At 30%

On Monday, the U.S. and China agreed to a temporary reduction in most tariffs on each other&#8217;s goods, marking a considerable easing of trade tensions. As a result, major tech stocks caught in the trade war, such as Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Amazon (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) and Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), climbed more than 4% during the pre-market trading session.
What Happened: The world&#8217;s two largest economies have agreed to a 90-day suspension of &#8220;reciprocal&#8221; tariffs, reducing them from 125% to 10%.&nbsp;However, the U.S. will maintain its 20% tariffs on Chinese imports linked to fentanyl, keeping the overall tariff level on China at 30%, <a href="https://www.cnbc.com/2025/05/12/us-and-china-agree-to-slash-tariffs-for-90-days.html">reported </a>CNBC.
As per the joint statement, Beijing has also agreed to suspend or lift all non-tariff countermeasures imposed since April 2, including sanctions on certain U.S. companies and export restrictions on key minerals, <a href="https://www.scmp.com/economy/global-economy/article/3309975/china-us-reduce-majority-tariffs-after-first-round-trade-talks?module=top_story&amp;pgtype=homepage">as per</a> the South China Morning Post.
This development comes after intensive trade talks between U.S. and Chinese representatives in Switzerland, with U.S. Treasury Secretary Scott Bessent expressing satisfaction with the discussions, stating, &#8220;We had very productive talks&nbsp;and I believe that the&nbsp;venue, here in Lake Geneva,&nbsp;added great equanimity to what&nbsp;was a very positive process.&#8221;
"Neither side wants a decoupling,&#8221; emphasized Bessent. 
Both countries have signaled their commitment to ongoing dialogue on economic and trade policy. Earlier in the day, the official handle of the Chinese Embassy in the U.S. stated, &#8220;high-level meeting on economic and trade affairs were in-depth, candid and constructive,&#8221; citing Chinese Vice Premier He Lifeng.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/05/45314762/charlie-munger-was-once-asked-why-warren-buffett-was-so-much-richer-and-replied-he-got-an-earlier-start-before-adding-why-was-albert-einstein-poorer-than-i-was" target="_blank" rel="noreferrer noopener">Charlie Munger Was Once Asked Why Warren Buffett Was So Much Richer — He Replied, &#8216;He Got An Earlier Start,&#8217; Then Added, &#8216;Why Was Albert Einstein Poorer Than I Was?&#8217; &#8211; Benzinga</a>
Why It Matters: The weekend talks in Geneva, Switzerland, marked the first formal negotiations between the two superpowers since U.S. President Donald Trump imposed new tariffs of 145% on China earlier this year. Trump had stated that he "might speak with Chinese President Xi Jinping" based on the outcome in Switzerland.
This agreement comes in the wake of renewed<a href="https://www.benzinga.com/news/global/25/05/45337811/trump-announces-total-reset-as-us-china-trade-talks-aim-to-end-tariff-war"> trade negotiations </a>between the two nations, as reported. The talks, described by U.S. officials and President Trump as a potential &#8220;reset,&#8221; aimed to reduce tariffs and reestablish more stable trade terms. 
Despite the diplomatic tone, deep-rooted differences remain, particularly around technology, subsidies, and market transparency. The outcome of these talks is critical not just for U.S.–China relations, but for global trade stability in the months ahead. 
Investors were encouraged by the news of the tariff relief. During the pre-market trading session, shares of Apple (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAPL#NASDAQ">AAPL</a>), Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) climbed above 4%, while Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) and Amazon Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) rose more than 6%. Meanwhile, Boeing (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BA#NYSE">BA</a>) rose 3.5%.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/25/05/45339953/apple-exec-says-iphone-users-are-ditching-google-search-now-chamath-palihaptiya-urges-the-tech-giant-to-stop-wait" target="_blank" rel="noreferrer noopener">Apple Executive Says iPhone Users Are Ditching Google — Now Chamath Palihaptiya Urges The Search Giant To Stop Waiting For Data And Start Fighting Models Like ChatGPT</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

AAPL

AMZN

NVDA

Apple, Amazon, Nvidia Rise In Monday Premarket As US, China Agree To 90-Day Tariff Truce: 'Neither Side Wants A Decoupling'

The CNN Money Fear and Greed index showed almost no change in the overall market sentiment, while the index remained in the &#8220;Greed&#8221; zone on Friday.
U.S. stocks settled lower on Friday, with the Dow Jones index falling more than 100 during the session ahead of trade talks between the US and Chinese officials.
Major indices on the US also closed lower last week, with the S&amp;P 500 falling about 0.5% and the Nasdaq down around 0.3%. The Dow also declined almost 0.2% in the week.
Lyft, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYFT#NASDAQ">LYFT</a>) reported better-than-expected earnings for the first quarter and announced a $750 million share buyback plan on Thursday. EchoStar Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SATS#NASDAQ">SATS</a>) reported wider-than-expected loss for the first quarter on Friday.
On the economic data front, U.S. initial jobless claims declined by 13,000 to 228,000 in the week ending May 3, compared to market estimates of 230,000. U.S. labor productivity in the nonfarm business sector declined by 0.8% during the first quarter compared to estimates of a 0.7% drop.
Most sectors on the S&amp;P 500 closed on a positive note, with real estate, consumer discretionary and energy stocks recording biggest gains on Friday. However, health care and communication services stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed lower by around 119 points to 41,249.38 on Friday. The S&amp;P 500 fell 0.07% to 5,659.91, while the Nasdaq Composite gained 0.01% at 17,928.92 during Friday's session.
Investors are awaiting earnings results from DaVita Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DVA#NYSE">DVA</a>), Fox Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FOX#NASDAQ">FOX</a>) and NRG Energy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NRG#NYSE">NRG</a>) today.
At a current reading of 61.6, the index was in the &#8220;Greed&#8221; zone on Friday, versus a prior reading of 61.5.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based
&nbsp;on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45315727/top-3-industrials-stocks-that-may-collapse-in-may">Top 3 Industrials Stocks That May Collapse In May</a> </li>
</ul>
Photo via Shutterstock

LYFT

SATS

Dow Falls Over 100 Points, Also Records Weekly Loss: Fear & Greed Index Remains In 'Greed' Zone

Prominent investor Ross Gerber recently shared that, in his view, Alphabet Inc.&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) subsidiary Google-backed Waymo self-driving technology performs better than human drivers, hinting at growing pressure on ride-sharing and autonomous vehicle rivals.
What Happened: The CEO and co-founder of Gerber Kawasaki Wealth and Investment Management shared his experience on his X account after observing a Waymo vehicle navigate through congested beach traffic. 
&#8220;A Waymo navigated by us with precision that was better than a human. Waymos drive extremely well,&#8221; Gerber stated, adding that this development &#8220;is going to be very tough competition&#8221; for Uber Technologies Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) and Elon Musk&#8216;s Tesla Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
Gerber&#8217;s comments came in response to CBS Sunday Morning correspondent David Pogue&#8216;s segment highlighting Waymo&#8217;s achievement of 50 million miles driven without a fatality. According to Pogue&#8217;s report, Waymo plans expansion to 15 cities by year-end, offering rides at the &#8220;same price as Uber.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Yesterday in just packed beach traffic and horrid tourist drivers. A Waymo navigated by us with precision that was better than a human. Waymos drive extremely well. This is going to be very tough competition for uber and tesla. <a href="https://twitter.com/search?q=%24uber&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$uber</a> <a href="https://twitter.com/search?q=%24tsla&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$tsla</a> <a href="https://twitter.com/search?q=%24goog&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$goog</a> <a href="https://t.co/0VrfRYfYLM">https://t.co/0VrfRYfYLM</a>
&mdash; Ross Gerber (@GerberKawasaki) <a href="https://twitter.com/GerberKawasaki/status/1921629990283530368?ref_src=twsrc%5Etfw">May 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/25/05/45340216/openais-ipo-ambitions-hang-in-the-balance-as-microsoft-negotiates-equity-report">OpenAI&#8217;s IPO Ambitions Hang In The Balance As Microsoft Negotiates Equity: Report</a>
Why It Matters: The assessment from Gerber directly contradicts the position of prominent Tesla bull and Wedbush Securities analyst Dan Ives, who recently dismissed the Waymo and Toyota Motor Corp&#8216;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TM#NYSE">TM</a>) partnership as a <a href="https://www.benzinga.com/25/05/45126638/tesla-will-own-the-autonomous-market-dan-ives-says-shrugging-off-waymo-toyota-agreement">threat to Tesla&#8217;s autonomous ambitions</a>. &#8220;Tesla will own the autonomous market in my view and no one can compete with their scale and scope,&#8221; Ives posted, emphasizing Tesla&#8217;s upcoming Austin robotaxi launch in June as a &#8220;key chapter of growth.&#8221;
Waymo has established significant momentum in the autonomous vehicle race, recently announcing <a href="https://www.benzinga.com/25/04/45001569/waymo-announces-250000-weekly-paid-rides-across-four-us-cities-sundar-pichai-says-personal-ownership-an-option-in-the-future">it provides over 250,000</a> fully autonomous paid rides weekly across four major cities. 
The Alphabet subsidiary has formed a strategic partnership with Toyota to develop autonomous technology for personally owned vehicles, combining Waymo&#8217;s driving system expertise with Toyota&#8217;s manufacturing capabilities.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45339797/gary-black-doubles-down-on-ubers-autonomy-upside-reflects-on-tesla-debates-i-was-right-on-volume-pr-and-robotaxis">Gary Black Doubles Down On Uber&#8217;s Autonomy Upside, Reflects Debates With Tesla Faithful: &#8216;I Was Right&#8217;</a></li>
</ul>
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
Image Via Shutterstock

Opinion

GOOG

GOOGL

UBER

Ross Gerber Calls Google-Backed Waymo's Self-Driving Taxis 'Better Than A Human,' Says They're 'Tough Competition' For Uber And Tesla

Economists have been predicting that retailers in the U.S. are likely to face pressure in the case of higher tariffs on China, as it is likely to &#8220;empty shelves&#8221; with a falling inventory-to-sales ratio.
What Happened: According to Torsten Slok, the chief economist at Apollo Academy, the inventory-to-sales ratio for retailers has fallen below the pre-pandemic level, sparking concerns about lower inventory as compared to the sales made by these retailers.
&#8220;The inventory-to-sales ratio for retailers was 1.5 before the pandemic, and now it is 1.3, see chart below,&#8221; the Apollo note stated.
Slok explained, &#8220;In other words, retailers will more quickly have empty shelves when goods no longer come in from China.&#8221;
This sentiment was also echoed by senior economist Mohamed El Erian in an X post. According to him, the ongoing high-level talks between China and the U.S. in Geneva, Switzerland, are likely to provide clarity on many concerns.
He highlights China&#8217;s &#8220;appetite for pain&#8221; and America&#8217;s fear of &#8220;empty shelves&#8221; as the primary matters that need to be solved via the ongoing talks.
&#8220;The outcome of this weekend's China-US tariff talks in Switzerland will be assessed in terms of what it reveals about China's appetite for pain, America's fear of &#8217;empty shelves,&#8217; and the way each country prioritizes the long-term objectives of trade policy. It will also be significant for many other countries, where there is already concern about the diversion of Chinese exports to their markets,&#8221; he said.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">An interesting week ahead for the global economy and markets, including on account of China-US tariff talks, the follow-up to the Federal Reserve policy meeting, and data: The outcome of this weekend's China-US tariff talks in Switzerland will be assessed in terms of what it…
&mdash; Mohamed A. El-Erian (@elerianm) <a href="https://twitter.com/elerianm/status/1921319822274523284?ref_src=twsrc%5Etfw">May 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
See Also: <a href="https://www.benzinga.com/government/regulations/25/05/45340465/bill-ackman-slams-subsidies-for-contributing-to-37-trillion-national-debt-hails-trumps-drug-price-order">Bill Ackman Slams Subsidies For Contributing To $37 Trillion National Debt, Hails Trump&#8217;s Drug Price Order</a>
Why It Matters: Over the weekend, the White House and Chinese officials signaled significant <a href="https://www.benzinga.com/news/global/25/05/45337811/trump-announces-total-reset-as-us-china-trade-talks-aim-to-end-tariff-war">headway in trade negotiations</a> held in Geneva.
Treasury Secretary Scott Bessent lauded the &#8220;substantial progress,&#8221; while Trade Ambassador Jamieson Greer highlighted the swift agreement, expressing optimism that the deal would address the U.S.&#8217;s $1.2 trillion trade deficit, a &#8220;national emergency.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">BREAKING: U.S. Announces China Trade Deal in Geneva <a href="https://t.co/JjgvYAvAGe">pic.twitter.com/JjgvYAvAGe</a>
&mdash; The White House (@WhiteHouse) <a href="https://twitter.com/WhiteHouse/status/1921623939060519353?ref_src=twsrc%5Etfw">May 11, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
China&#8217;s Vice Commerce Minister Li Chenggang also announced an &#8220;important consensus,&#8221; predicting &#8220;good news for the world,&#8221; according to Reuters. Both sides indicated that details of this progress would be released on Monday.
Price Action: The SPDR S&amp;P 500 ETF Trust (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPY#NYSE">SPY</a>) and Invesco QQQ Trust ETF (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QQQ#NASDAQ">QQQ</a>), which track the S&amp;P 500 index and Nasdaq 100 index, respectively, fell on Friday. The SPY was down 0.13% to $564.34, while the QQQ declined 0.066% to $487.97, according to <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a> data.
On Monday, the futures of S&amp;P 500, Dow Jones and Nasdaq 100 were trading higher ahead of the pre-open.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/government/regulations/25/05/45311562/mohamed-el-erian-flags-adverse-implications-for-domestic-industries-as-chinas-exports-rise-8-despite-21-drop-in-us-shipments" target="_blank" rel="noreferrer noopener">Mohamed El-Erian Flags ‘Adverse Implications' For Domestic Industries As China's Exports Rise 8% Despite 21% Drop In US Shipments</a></li>
</ul>
Photo: Orlowski Designs LLC/Shutterstock

Analyst Color

Market Summary

Regulations

Broad U.S. Equity ETFs

Futures

Analyst Ratings

ETFs

Economists Warn Of 'Empty Shelves' If Goods Stop Coming From China Amid Falling Inventory-To-Sales Ratio And Potential Tariffs

ACHC

ACHR

ACNT

AGEN

AIRJ

ALLT

ALTI

AMBC

AMPY

APEI

AQST

ARCT

ARWR

ASRT

ASYS

AUPH

BATRA

BATRK

Mobile Infrastructure Corporation Common Stock

BEEP

BETR

Bakkt Holdings, Inc. Class A Common Stock

BKKT

BLDE

BLNK

CATX

CEPU

CHGG

CHRS

CLLS

CLPR

CMCL

CMPO

CNNE

CNTY

CPSS

CTMX

CTRI

CWCO

DOLE

EDIT

EXOD

FGEN

FOXA

FRPH

FTEK

FTRE

GAIA

GETY

GPRO

GRDN

HBIO

HFFG

HNRG

IHRT

IMNN

INDI

ISPR

KBDC

KPTI

KSPI

LAND

LEGH

LINC

LSEA

LTBR

METC

Ramaco Resources, Inc. - Class B Common Stock

METCB

MFIC

MLNK

MLYS

MNDY

MODG

MRVI

MVIS

MVST

NMRA

NOTE

NPWR

NRGV

NRXS

Earnings Scheduled For May 12, 2025

On Sunday, President Donald Trump announced on Truth Social that he plans to sign what he called the &#8220;<a href="https://www.benzinga.com/general/health-care/25/05/45339399/trump-says-prescription-drug-prices-set-to-drop-by-30-to-80-almost-immediately-thanks-to-most-favored-nation-plan-mark-cuban-urges-president-to-force-tran">most consequential executive order</a>&#8221; in U.S. history, aimed at lowering prescription drug prices.
What Happened: Trump said the executive order, set to be signed at 9 a.m. Monday, will implement a &#8220;Most Favored Nations&#8221; policy requiring pharmaceutical companies to charge U.S. consumers no more than the lowest price they offer for the same drug in any other country.
See More: <a href="https://www.benzinga.com/25/05/45338985/trump-reportedly-set-to-accept-flying-palace-from-qatar-white-house-says-lavish-gift-of-boeing-jumbo-jet-complies-with-all-applicable-laws">Trump Reportedly Set To Accept &#8216;Flying Palace&#8217; From Qatar, White House Says Lavish Gift Of Boeing Jumbo Jet Complies With &#8216;All Applicable Laws&#8217;</a>
Accusing pharmaceutical companies of overcharging American consumers, sometimes &#8220;five to ten times more&#8221; than patients in other countries, Trump slammed political opponents for enabling the status quo all these years.
Trump says that prescription drug prices will be reduced by &#8220;30% to 80%,&#8221; while rising throughout the world, to equalize and &#8220;bring fairness to America.&#8221;
Why It Matters: This move is expected to have the biggest impact on Medicare Part B drugs, which mainly constitute outpatient prescriptions and biologicals, the prices for which are directly managed by the Centers for Medicare &amp; Medicaid Services (CMS).
<figure class="wp-block-table"> 
<table class="has-fixed-layout">
<thead>
<tr>
<th class="has-text-align-center" data-align="center">Drug Name</th>
<th class="has-text-align-center" data-align="center">Manufacturer(s)</th>
<th class="has-text-align-center" data-align="center">Total Spending</th>
<th class="has-text-align-center" data-align="center">Primary Use</th>
</tr>
</thead>
<tbody>
<tr>
<td class="has-text-align-center" data-align="center">Keytruda</td>
<td class="has-text-align-center" data-align="center">Merck &amp; Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>)</td>
<td class="has-text-align-center" data-align="center">$4.0B</td>
<td class="has-text-align-center" data-align="center">Cancer (various types)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Eylea</td>
<td class="has-text-align-center" data-align="center">Regeneron Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) </td>
<td class="has-text-align-center" data-align="center">$3.4B</td>
<td class="has-text-align-center" data-align="center">Macular degeneration</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Prolia/Xgeva</td>
<td class="has-text-align-center" data-align="center">Amgen Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>)</td>
<td class="has-text-align-center" data-align="center">$2.1B</td>
<td class="has-text-align-center" data-align="center">Osteoporosis, bone metastases</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Opdivo</td>
<td class="has-text-align-center" data-align="center">Bristol-Myers Squibb Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) </td>
<td class="has-text-align-center" data-align="center">$2.0B</td>
<td class="has-text-align-center" data-align="center">Cancer (various types)</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Darzalex</td>
<td class="has-text-align-center" data-align="center">Johnson &amp; Johnson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JNJ#NYSE">JNJ</a>)</td>
<td class="has-text-align-center" data-align="center">$1.9B</td>
<td class="has-text-align-center" data-align="center">Multiple myeloma</td>
</tr>
<tr>
<td class="has-text-align-center" data-align="center">Avastin</td>
<td class="has-text-align-center" data-align="center">Roche Holdings AG (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RHHBY#OTC">RHHBY</a>)</td>
<td class="has-text-align-center" data-align="center">$1.8B</td>
<td class="has-text-align-center" data-align="center">Cancer (various types)</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">A breakdown of the top Medicare Part B drugs by spending in 2023, based on the latest data shared by the Centers for Medicare &amp; Medicaid Services (CMS).</figcaption></figure>
These are the stocks that are most likely to be hit by this announcement when markets open on Monday, given their sizable exposure to Medicare, especially being classified as Part B. 
According to a report by the Rand Corporation, a California-based policy think-tank, prescription drug prices in the U.S. are, on average, at least 2.78 times higher than other countries.
While Trump&#8217;s move is being criticized by the likes of crypto enthusiast Ed Krassenstein, calling it &#8220;just another Trump lie,&#8221; saying that an executive order can steer Medicare and Medicaid payments, but <a href="https://www.benzinga.com/general/health-care/25/05/45339399/trump-says-prescription-drug-prices-set-to-drop-by-30-to-80-almost-immediately-thanks-to-most-favored-nation-plan-mark-cuban-urges-president-to-force-tran">cannot force manufacturers</a> to cut prices. 
Others, such as billionaire investor Mark Cuban, have come out in support of the move, saying that it can &#8220;force transparency,&#8221; even if the President cannot force price cuts.
Drug pricing disparities have been a point of contention across the political spectrum. Recently, Novo Nordisk A/S&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) CEO, Lars Fruergaard Jorgensen, <a href="https://www.benzinga.com/general/biotech/24/09/40986953/novo-nordisk-ceo-to-face-senate-scrutiny-over-high-ozempic-and-wegovy-prices-hearing-scheduled-on">faced Senate scrutiny</a> on these vast differences, where he was targeted by Sen.&nbsp;Bernie Sanders&nbsp;(I-Vt.) for the high price of the company&#8217;s diabetes drug, Ozempic. 
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="135" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-1024x135.png" alt="" class="wp-image-911404" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-1024x135.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-300x40.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-768x101.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM-1536x202.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12033045/Screenshot-2025-05-12-at-1.00.28-PM.png 1594w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Novo Nordisk shares have an unfavorable price trend in the short, medium, and long term, but how does it compare with peers such as Johnson &amp; Johnson, Amgen, and Roche? Sign up for <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-2#:~:text=Turn%20Market%20Chaos,when%20markets%20rebound">Benzinga Edge</a> to find out.
Meanwhile, Novo Nordisk, Pfizer and J&amp;J were trading at least 3% lower in Monday premarket. 
Photo Courtesy: create jobs 51 On Shutterstock.com
Read More: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/25/05/45339784/mohamed-el-erian-warns-us-china-deal-reveals-americas-fear-of-empty-shelves-as-markets-rally-on-trade-optimism-peter-schiff-skeptical-without-renminbi-revaluation">Mohamed El-Erian Warns US-China Deal Reveals &#8216;America&#8217;s Fear Of Empty Shelves&#8217; As Markets Rally On Trade Optimism, Peter Schiff Skeptical Without Renminbi Revaluation</a></li>
</ul>

AMGN

REGN

RHHBY

Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket

The Federal Aviation Administration (FAA) is reportedly considering reducing the number of flights operating out of New Jersey's Newark Airport.
What Happened: The agency is set to meet with officials from several U.S. airlines to discuss scaling back flights out of Newark following disruptions caused by equipment malfunctions as well as staff shortages, CNBC reported <a href="https://www.cnbc.com/2025/05/11/newark-airport-flight-cuts-ahead-after-wee.html">on</a> Sunday.
"What you see in Newark is going to happen in other places across the country. It needs to be fixed," U.S. Transportation Secretary Sean Duffy said, according to the report.
Equipment outages caused air traffic controllers to lose communication as well as flight monitoring capabilities for over 90 seconds last month. There were also delays to over 1,000 flights due to equipment failures, the report suggests. The event also led to several staff members going on leave.
Questions have been raised over the aging air traffic infrastructure, which could reportedly cost over $31 billion to revamp, as well as more hiring of air traffic controllers, the report said.
"In ideal weather, with full staffing and with perfectly functioning technology, the FAA tells us that the airport (Newark) can only handle 77 flights per hour. And yet, the FAA regularly approves schedules of 80+ flights per hour almost every day between 3:00 pm and 8:00 p.m.," United Airlines Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UAL#NASDAQ">UAL</a>) CEO Scott Kirby told employees in a note, according to the report.
Why It Matters: The news comes in as the U.S. aviation industry is dealing with a difficult quarter, as analysts have<a href="https://www.benzinga.com/analyst-ratings/analyst-color/25/04/45020724/airlines-face-significant-pressure-analysts-adjust-expectations-after-q1-results"> reset price targets </a>for several U.S. airlines following quarterly results.
American Airlines Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AAL#NASDAQ">AAL</a>) recently announced it was <a href="https://www.benzinga.com/25/04/44982328/american-airlines-flies-into-uncertainty-q1-revenue-miss-2025-outlook-pulled-but-debt-plan-on-track?_gl=1&#x2A;1yry3sk&#x2A;_gcl_au&#x2A;NTM5OTQ2NTE5LjE3NDcwMjQyNzY.&#x2A;_ga&#x2A;R1MyLjEuczE3NDcwMzM3NzAkbzIkZzEkdDE3NDcwMzM3NzAkajAkbDAkaDA.&#x2A;_ga_V7ZK73W7N0&#x2A;czE3NDcwMzM1MzkkbzMkZzEkdDE3NDcwMzQyNzAkajAkbDAkaDA.">pulling its 2025 outlook </a>as the airline's operating revenue declined slightly to $12.55 billion, a 0.15% YoY decline.
Elsewhere, JetBlue Airways Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JBLU#NASDAQ">JBLU</a>) is reportedly in talks with United Airlines over a <a href="https://www.benzinga.com/25/04/45093263/jetblue-in-talks-with-united-airlines-over-possible-partnership-report">possible partnership</a> between the two companies.
Check out more of Benzinga&#8217;s Future Of Mobility coverage by<a href="https://www.benzinga.com/topic/mobility"> following this link.</a>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/04/45035715/airbus-finalizes-deal-with-spirit-to-take-over-assets-paving-way-for-boeing-acquisition">Airbus Finalizes Deal With Spirit To Take Over Assets, Paving Way For Boeing Acquisition</a></li>
</ul>
Photo: Synthetic Messiah/Shutterstock

Politics

Travel

JBLU

FAA Mulls Cutting Flights At Newark Airport Amid Staffing Woes And Equipment Failures: Report

Eli Lilly and Company&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LLY#NYSE">LLY</a>) Zepbound demonstrated superior weight reduction compared to Novo Nordisk A/S&#8217;s (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) Wegovy in a 72-week head-to-head trial.
What Happened: Participants treated with tirzepatide (Zepbound) achieved an average weight loss of 20.2%, compared to 13.7% with semaglutide (Wegovy), representing a 47% greater relative weight reduction, according to detailed results from a direct comparison trial published in The New England Journal of Medicine. 
On average, those taking Zepbound lost 50.3 pounds, while those on Wegovy lost 33.1 pounds over the course of the study.
The SURMOUNT-5 Phase 3b open-label clinical trial met its primary endpoint and all five key secondary endpoints, with Zepbound showing superiority across all weight reduction targets. Nearly 65% of Zepbound users achieved at least 15% weight loss compared to 40% on Wegovy, and participants experienced greater waist circumference reduction —7.2 inches versus 5.1 inches.
The safety profile aligned with previous trials, with primarily gastrointestinal-related adverse events that were generally mild to moderate in severity. Discontinuation rates due to adverse events were 6.1% for Zepbound versus 8% for Wegovy.
See Also: <a href="https://www.benzinga.com/25/05/45340117/peter-lynch-said-the-suckers-going-up-is-no-buy-strategy-suggests-two-things-to-look-for-in-a-company-that-suggest-something-different">Peter Lynch Once Lamented People Are &#8216;Careful&#8217; When They Buy A Fridge But Will &#8216;Drop Thousands&#8217; On A Stock Tip They Heard On A Bus</a>
Why It Matters: Zepbound&#8217;s performance in this direct comparison strengthens Lilly&#8217;s position in the rapidly growing weight loss medication market. The drug operates as a dual GIP and GLP-1 receptor agonist, compared to Wegovy, which works solely as a GLP-1 receptor agonist.
The U.S. Food and Drug Administration recently expanded Zepbound&#8217;s approval to include <a href="https://www.benzinga.com/news/25/01/42933134/fda-approves-weight-loss-drug-zepbound-for-sleep-apnea-will-insurance-cover-this-1000-per-month-medication">treatment for moderate-to-severe obstructive sleep apnea</a> in adults with obesity. Clinical trials showed patients experienced an average of 25 fewer breathing interruptions per hour, with up to 50% no longer exhibiting OSA symptoms after one year.
WW International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WW#NASDAQ">WW</a>) recently announced a <a href="https://www.benzinga.com/news/25/04/45073094/weightwatchers-integrates-with-eli-lilly-to-expand-access-to-zepbound-stock-skyrockets-110">partnership with LillyDirect</a> pharmacy provider Gifthealth to simplify access to Zepbound for eligible self-pay clinic members. According to WeightWatchers, 33% of its clinic patients currently use Zepbound as part of their weight management plan, with prescriptions more than doubling in recent months.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45339966/bitcoin-creator-satoshi-nakamotos-estimated-wealth-crosses-bill-gates-amid-apex-cryptos-sharp-rebound">Bill Gates Left Behind By Satoshi Nakamoto: Bitcoin Creator&#8217;s Wealth Now Eclipses That Of Microsoft Co-Founder Amid Crypto&#8217;s Sharp Rebound</a></li>
</ul>
Image Via Shutterstock 
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial

monday.com Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNDY#NASDAQ">MNDY</a>) will release earnings results for the first quarter, before the opening <a href="https://www.benzinga.com/quote/mndy/earnings">bell on Monday, May 12.</a>
Analysts expect the Tel Aviv, Israel-based company to report quarterly earnings at 70 cents per share, up from 61 cents per share in the year-ago period. monday.com projects to report quarterly revenue at $275.96 million, compared to $216.91 million a year earlier, according to data from <a href="https://pro.benzinga.com/dashboard">Benzinga Pro</a>.
On Feb. 10, Monday.com reported fiscal fourth-quarter revenue growth of 32% year-on-year to $267.98 million, beating the analyst consensus estimate of $261.37 million.
monday.com shares fell 1.2% to close at $278.24 on Friday.
Benzinga readers can access the latest analyst ratings on the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/22/09/28888638/exclusive-study-finds-benzinga-analyst-ratings-data-yields-market-beating-strategie">Analyst Stock Ratings</a> page. Readers can sort by stock ticker, company name, analyst firm, rating change or other variables.
Let's have a look at how Benzinga's most-accurate <a href="https://www.benzinga.com/quote/MNDY/analyst-ratings">analysts have rated the company</a> in the recent period.
<ul class="wp-block-list">
<li>Piper Sandler analyst Brent Bracelin maintained an Overweight rating and cut the price target from $385 to $305 on April 23, 2025. This analyst has an accuracy rate of 74%.</li>
<li>Jefferies analyst Brent Thill maintained a Buy rating and slashed the price target from $400 to $360 on March 31, 2025. This analyst has an accuracy rate of 76%.</li>
<li>Tigress Financial analyst Ivan Feinseth maintained a Buy rating and raised the price target from $340 to $450 on Feb. 21, 2025. This analyst has an accuracy rate of 72%.</li>
<li>Goldman Sachs analyst Kash Rangan maintained a Buy rating and boosted the price target from $350 to $400 on Feb. 11, 2025. This analyst has an accuracy rate of 66%.</li>
<li>Keybanc analyst Jackson Ader upgraded the stock from Sector Weight to Overweight with a price target of $420 on Feb. 11, 2025. This analyst has an accuracy rate of 68%.</li>
</ul>
Considering buying MNDY stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><img loading="lazy" decoding="async" width="1024" height="571" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12035951/image-114-1024x571.png" alt="" class="wp-image-911439" style="width:547px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12035951/image-114-1024x571.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12035951/image-114-300x167.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12035951/image-114-768x428.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/12035951/image-114.png 1108w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45315727/top-3-industrials-stocks-that-may-collapse-in-may">Top 3 Industrials Stocks That May Collapse In May</a> </li>
</ul>
Photo via Shutterstock

Price Target

Monday.Com Gears Up For Q1 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts

President Donald Trump&#8216;s proposed millionaire tax, which aims to increase the tax rate on income over $2.5 million, is being seen as largely symbolic and unlikely to significantly impact revenue or inequality by experts.
What Happened: Howard Gleckman, from the Urban-Brookings Tax Policy Center, stated that the proposed tax change would not significantly affect revenue or inequality, <a href="https://fortune.com/2025/05/11/trump-millionaire-tax-inequality-billionaires/">reported</a> Fortune. The tax hike, which would increase the rate from 37% to 39.6% on income over $2.5 million, is expected to raise about $8.2 billion this year and impact around 80,000 households.
Most&nbsp;millionaires and billionaires in the&nbsp;U.S. earn a small portion&nbsp;of their income in the&nbsp;form of salaries, with the majority coming from capital gains, which are taxed at a lower rate. Program director at&nbsp;the Institute for Policy Studies,&nbsp;Sarah Anderson, told the publication that the proposed tax increase would have minimal impact on billionaires as&nbsp;they take very little compensation&nbsp;from their companies.
"It's not going to change the revenue very much and it's going to give a lot of Republicans heartburn," stated Garrett Watson from the Tax Foundation.
SEE ALSO:&nbsp;<a href="https://benzinga.com/news/25/05/45337485/this-is-bad-like-actually-bad-a-man-describes-the-crisis-at-a-big-fulfillment-warehouse-tariffs-are-hitting-" target="_blank" rel="noreferrer noopener">&#8216;This Is Bad. Like Actually Bad&#8217;—A Man Describes The Crisis At A Big Fulfillment Warehouse: Tariffs Are Hitting Way Harder Than We Thought</a>
Why It Matters: The Republican Party, long opposed to tax hikes, is now considering them to help cover $4.5 trillion in costs from extending the 2017 tax cuts and advancing Trump's priorities like exempting Social Security income and tips from taxes.
Trump&#8217;s tax proposal comes amid a political storm within the Republican Party. Trump&#8217;s support for a tax increase on millionaires <a href="https://www.benzinga.com/25/04/45037541/trumps-proposed-millionaires-tax-ignites-political-firestorm-within-republicans-doing-so-would-be-political-death-caution-experts">sparked controversy </a>and debate among Republicans and conservatives. Opposition to tax hikes is strong among traditional Republicans, including Trump advisors Steve Moore and Larry Kudlow and GOP Sen. Dave McCormick (R-Pa.) and Ted Cruz (R-Texas). However, Sen. Mike Crapo (R-Idaho) expressed potential openness to being persuaded.
Earlier in May, Trump&#8217;s ambitious budget package, dubbed the &#8220;Big, Beautiful Bill,&#8221; was facing a <a href="https://www.benzinga.com/markets/equities/25/05/45217098/trumps-big-beautiful-bill-takes-shape-gop-pushes-tax-cuts-border-wall-funding-and-deep-spending-reductions-ahead-of-memorial-day-deadline">bumpy road </a>in Congress as Republican lawmakers worked to balance tax cuts with spending priorities.
Just days later, Trump revived the push for a <a href="https://www.benzinga.com/news/25/05/45317302/trump-renews-effort-to-hike-taxes-on-wealthy-americans-holds-talks-with-mike-johnson-report">tax increase </a>on the wealthiest Americans as part of his forthcoming tax package. The White House believes that this tax increase on the wealthiest will facilitate substantial tax cuts for the middle and working class and safeguard Medicaid.
<ul class="wp-block-list">
<li>READ MORE:&nbsp;<a href="https://benzinga.com/25/05/45339953/apple-exec-says-iphone-users-are-ditching-google-search-now-chamath-palihaptiya-urges-the-tech-giant-to-stop-wait" target="_blank" rel="noreferrer noopener">Apple Executive Says iPhone Users Are Ditching Google — Now Chamath Palihaptiya Urges The Search Giant To Stop Waiting For Data And Start Fighting Models Like ChatGPT</a></li>
</ul>
Image via Shutterstock
Disclaimer:&nbsp;This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.

Trump's Millionaire Tax More Of A Symbolic Gesture Than Step Towards Reducing Inequality, Warn Experts: 'It's Going To Give A Lot Of Republicans Heartburn'

Diversified Energy Q1 Revenue $346.9M Up From $193.62M YoY, Adj. EBITDA $138.64M Up From $102.08M YoY

Press Releases

Exicure, Inc. Receives Extension from Nasdaq Hearings Panel

Exicure, Inc. Enters into Purchase Agreements for $1.3 Million and $8.7 Million Equity Financing and Reports Third Quarter 2024 Financial Results

Exicure, Inc. Announces Shareholders Approve the $8.7 Million Equity Financing and Reports Executive Management and Board Changes

Comments

Exicure

Notizie

Ultime notizie per Exicure (NASDAQ:XCUR) Azioni

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO